PMID- 34044517
OWN - NLM
STAT- MEDLINE
DCOM- 20210531
LR  - 20210531
IS  - 0376-2491 (Print)
IS  - 0376-2491 (Linking)
VI  - 101
IP  - 20
DP  - 2021 Jun 1
TI  - [Interstitial lung disease revisited].
PG  - 1453-1457
LID - 10.3760/cma.j.cn112137-2020831-02514 [doi]
AB  - Interstitial lung disease (ILD), consisting of more than 200 subtypes of 
      diseases, is a large group of heterogeneous diseases characterized by varying 
      degrees of alveolitis and pulmonary parenchymal fibrosis. There are many 
      challenges in its diagnosis and treatment. In recent years, new understanding of 
      the clinical classification, disease behavior, early diagnosis, and treatment of 
      ILD has been obtained. The anti-fibrotic drugs have been expanded successfully 
      from treatment of idiopathic pulmonary fibrosis (IPF) to progressive-fibrosing 
      interstitial lung diseases (PF-ILD). A new international clinical practice 
      guideline categorized hypersensitivity pneumonitis (HP) into two clinical 
      phenotypes, namely nonfibrotic and fibrotic HP. The clinical classification of 
      ILD according to disease behavior and a progressing fibrotic phenotype is of 
      important value for the establishment of treatment strategies for patients with 
      ILD. Interstitial pulmonary abnormalities (ILA) may represent the subclinical 
      stages of different types of ILD, and long-term follow-up of ILA is key to 
      improving the early diagnosis of ILD. Interstitial pneumonia with autoimmune 
      features (IPAF) may represent an early phase or prodromal state of a connective 
      tissue disease (CTD), and patients with IPAF need to be under longitudinal 
      surveillance for evolution to CTD.
FAU - Jiang, H D
AU  - Jiang HD
AD  - Department of Respiratory Medicine, Renji Hospital, School of Medicine, Shanghai 
      Jiao Tong University, Shanghai 200127, China.
FAU - Chen, B
AU  - Chen B
AD  - Department of Respiratory and Critical Care Medicine, Affiliated Hospital of 
      Xuzhou Medical University, Xuzhou 221000, China.
LA  - chi
PT  - Journal Article
PL  - China
TA  - Zhonghua Yi Xue Za Zhi
JT  - Zhonghua yi xue za zhi
JID - 7511141
SB  - IM
MH  - *Alveolitis, Extrinsic Allergic/diagnosis
MH  - *Connective Tissue Diseases
MH  - Humans
MH  - *Idiopathic Pulmonary Fibrosis/diagnosis
MH  - Lung
MH  - *Lung Diseases, Interstitial/diagnosis
MH  - Tomography, X-Ray Computed
EDAT- 2021/05/29 06:00
MHDA- 2021/06/01 06:00
CRDT- 2021/05/28 04:24
PHST- 2021/05/28 04:24 [entrez]
PHST- 2021/05/29 06:00 [pubmed]
PHST- 2021/06/01 06:00 [medline]
AID - 10.3760/cma.j.cn112137-2020831-02514 [doi]
PST - ppublish
SO  - Zhonghua Yi Xue Za Zhi. 2021 Jun 1;101(20):1453-1457. doi: 
      10.3760/cma.j.cn112137-2020831-02514.